Skip to main content

trifarotene (Aklief®)

 

Following a limited submission

AWMSG advice

Status: Recommended

For the cutaneous treatment of Acne Vulgaris of the face and/ or the trunk in patients from 12 years of age and older, when many comedones, papules and pustules are present.

 Trifarotene (Aklief) 3153 FAR (PDF, 380Kb)
 Appraisal report: trifarotene (Aklief) 3153 (PDF, 254Kb)
 Equality Impact Assessment: trifarotene (Aklief) 3153 (PDF, 194Kb)

Medicine details

Medicine name trifarotene (Aklief®)
Formulation 50 microgram/g cream
Reference number 3153
Indication

As above

Company Galderma (UK) Ltd
BNF chapter Skin
Submission type Limited
Status Recommended
Advice number 0124
NMG meeting date 28/02/2024
AWMSG meeting date 17/04/2024
Date of issue 29/04/2024
Follow AWTTC: